Evexia Lifecare Ltd Plans Major Expansion; To Enter Into Bullion Trading

Vadodara (Gujarat) [India], October 11: BSE listed (524444), Evexia Lifecare Limited has received initial plant layout permission from FDA to setup Active Pharmaceutical Ingredient (API) manufacturing plant of Isometamidium (Isometa) in addition to the current ongoing commercial activity, mainly used for the rare diseases in cattle, buffalo, goat, dogs, etc. Very few companies are manufacturing the said API in India and worldwide. The Company has completed the application process for environment clearance with the concerned government authority and has procured all the required plant and machinery at the Vadodara plant location. Once the Company receives the Environment Clearance (EC) from the concerned Government Authorities, the installation and production work will commence.

Further, the Board of Directors of one of the subsidiary companies, namely Kavit Trading Private Limited, where Evexia holds 70% of the shareholding, has approved the business of direct buying of bullion from the Banks and selling in the market. The said subsidiary company has approached bankers for the opening of Bullion Accounts with them. This new business will boost the revenue of the said subsidiary company and consequently improve the Company’s consolidated financials.

Apart from the ISOMETA API product, Evexia Lifecare Limited is also planning to manufacture intermediate, mainly used for anti-diabetic and heart diseases, at Vadodara based plant location. The Research & Development (R & D) team is at the final stage of five more products that the Company may launch by November 2021.

The Company is at an advanced stage of acquiring Akola (Maharashtra) based existing plant of one of the manufacturers of ISOMETA API, which will increase production capacity and profitability.

The Company’s vision is to enter into formulation by January 2022, which will give a push to the Company’s growth for the long term. The R & D team has already started work for the formulation plant, looking into the opportunity and available market in India and across the globe.

The Company has started its new branch at Hyderabad location to trade pharmaceutical chemicals, and the same will likely contribute Rs. 25-30 Cr turnover per year.

For the above all expansion activities, the Company will manage the funds internally, and the board is not expecting any external borrowings.

Related Posts

Auric Metal and PVD Solution Expands across Asia with its Largest PVD Coating Machine Chamber

New Delhi (India), May 23: Auric Metal & PVD Solution, a leading provider of premium PVD Coated products and services, is proud to announce its expansion into the Asian market…

Fuaark: Surat Based Trio Turned Rs 4 Lakh Investment Into a Rs 36 CR Business

Surat (Gujarat) [India], May 23: In the bustling city of Surat, a revolutionary brand emerged, reshaping the landscape of fitness apparel. FUAARK, a term that resonates with the energy and…

You Missed

Asian Granito India Ltd reports Consolidated Net Sales of Rs. 1531 crore in FY24

  • May 23, 2024
Asian Granito India Ltd reports Consolidated Net Sales of Rs. 1531 crore in FY24

The Lions’ Den Roars to Life, Promising a Fair Play in the Jungle of Startup Funding

  • May 23, 2024
The Lions’ Den Roars to Life, Promising a Fair Play in the Jungle of Startup Funding

Saubhagyam New Tower Launch: Today Global Developers Continue the Journey of Happy Stories

  • May 23, 2024
Saubhagyam New Tower Launch: Today Global Developers Continue the Journey of Happy Stories

Student Living Experience Platform FretBox Secures Seed Investment Led by CXO Factor

  • May 22, 2024
Student Living Experience Platform FretBox Secures Seed Investment Led by CXO Factor

Celebrate the Birth of Enlightenment at The Bodhi Palace Resort, Bodhgaya

  • May 21, 2024
Celebrate the Birth of Enlightenment at The Bodhi Palace Resort, Bodhgaya

Ajooni Biotech Ltd’s Rs. 43.81 crores Rights opens on May 21, 2024

  • May 20, 2024
Ajooni Biotech Ltd’s Rs. 43.81 crores Rights opens on May 21, 2024